STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $123,000 | +4.2% | 11,125 | -13.3% | 0.00% | 0.0% |
| Q2 2017 | $118,000 | +140.8% | 12,825 | +22.1% | 0.00% | – |
| Q1 2016 | $49,000 | -55.0% | 10,500 | -39.0% | 0.00% | -100.0% |
| Q4 2015 | $109,000 | +22.5% | 17,200 | +70.3% | 0.00% | 0.0% |
| Q3 2015 | $89,000 | -35.0% | 10,100 | -12.9% | 0.00% | 0.0% |
| Q2 2015 | $137,000 | -18.5% | 11,600 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $168,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |